Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-131908
Filing Date
2024-11-29
Accepted
2024-11-29 16:30:05
Documents
4
Period of Report
2024-11-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A nov_24_rdo_sp_mt_proxy_p.htm PRE 14A 214769
2 GRAPHIC img148877716_0.jpg GRAPHIC 4888
3 GRAPHIC img148877716_1.jpg GRAPHIC 1259582
4 GRAPHIC img148877716_2.jpg GRAPHIC 150845
  Complete submission text file 0000950170-24-131908.txt   2163540
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-12830 | Film No.: 241516621
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)